tiprankstipranks
Lineage Cell Therapeutics, Inc. (DE:BT3)
FRANKFURT:BT3

Lineage Therap (BT3) Revenue

1 Followers

Lineage Therap Revenue

Lineage Therap had a revenue of 1.07M in the quarter ending Jun 30, 2026, with -38.03%. This bring the company's revenue in the last twelve months to 13.08M, Increased -11.48%. In the fiscal year ending Dec 31, 2025, Lineage Therap had annual revenue of 14.56M with 53.24% growth.
Revenue (ttm)
13.08M
Revenue Growth
12.26%
P/S Ratio
15.41
Revenue/Employee
€194,080
Employees
75
Market Cap
€224.33M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
14.56M5.06M+53.24%
Dec 31, 2024
9.50M554.00K+6.19%
Dec 31, 2023
8.95M-5.76M-39.16%
Dec 31, 2022
14.70M10.81M+277.39%
Dec 31, 2021
3.90M3.12M+404.01%
Dec 31, 2020
773.00K-705.00K-47.70%
Dec 31, 2019
1.48M62.00K+4.38%
Dec 31, 2018
1.42M-376.00K-20.98%
Dec 31, 2017
1.79M